7 - 10 days
Test Updated:
PLA2R
Anti-PLA2R
Anti-Phospholipase A2 Receptor Antibody
Phospholipase A2 Receptor Autoantibody
Looking to order a test?
We’ve provided helpful links to make ordering easy.
Find a RequisitionAll specimens should be accompanied by a requisition.
Submitting SpecimensLearn about how to properly label and where to ship specimens.
Order Kits and SuppliesMLabs provides all the supplies necessary for the collection of specimens.
Test FAQVisit our provider FAQ and learn about common questions to ordering tests.
Test Overview
Enzyme Linked Immunosorbent Assay (ELISA)
Approximately 75-80% of patients have serum autoantibodies to the M-type phospholipase A2 receptor (PLAR2). In contrast, less than 10% of patients with secondary membranous nephropathy, other forms of glomerulonephritis, as well as healthy individuals are positive for autoantibody to the PLA2R antibody. An increase, decrease or disappearance generally precedes a change in the clinical status, thus the antibody titer has a predictive value with respect to clinical remission, relapse, or risk assessment after kidney transplantation. A test for colocalization of PLA2R and IgG4 of kidney tissue is recommended in seronegative samples to confirm or exclude a diagnosis of PLA2R antibody-mediated MGN.
Positive: >20 U/mL Borderline: 14 to 20 U/mL Negative: <14 U/mL.
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.